Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

548 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
Brandão M, Martins-Branco D, De Angelis C, Vuylsteke P, Gelber RD, Van Damme N, van Walle L, Ferreira AR, Lambertini M, Poggio F, Verhoeven D, Barbeaux A, Duhoux FP, Wildiers H, Caballero C, Awada A, Piccart-Gebhart M, Punie K, de Azambuja E. Brandão M, et al. Among authors: awada a. Breast Cancer Res Treat. 2024 Apr 9. doi: 10.1007/s10549-024-07275-0. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38592543 No abstract available.
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
Brandão M, Martins-Branco D, De Angelis C, Vuylsteke P, Gelber RD, Van Damme N, van Walle L, Ferreira AR, Lambertini M, Poggio F, Verhoeven D, Barbeaux A, Duhoux FP, Wildiers H, Caballero C, Awada A, Piccart-Gebhart M, Punie K, de Azambuja E. Brandão M, et al. Among authors: awada a. Breast Cancer Res Treat. 2024 Jan;203(2):351-363. doi: 10.1007/s10549-023-07116-6. Epub 2023 Oct 25. Breast Cancer Res Treat. 2024. PMID: 37878152
Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO).
Fontaine C, Renard V, Van den Bulk H, Vuylsteke P, Glorieux P, Dopchie C, Decoster L, Vanacker L, de Azambuja E, De Greve J, Awada A, Wildiers H. Fontaine C, et al. Among authors: awada a. Breast Cancer Res Treat. 2019 Aug;176(3):607-615. doi: 10.1007/s10549-019-05259-z. Epub 2019 May 8. Breast Cancer Res Treat. 2019. PMID: 31069589 Clinical Trial.
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors.
Franzoi MA, Vandeputte C, Eiger D, Caparica R, Brandão M, De Angelis C, Hendlisz A, Awada A, Piccart M, de Azambuja E. Franzoi MA, et al. Among authors: awada a. Breast Cancer Res Treat. 2020 May;181(1):199-209. doi: 10.1007/s10549-020-05617-2. Epub 2020 Apr 3. Breast Cancer Res Treat. 2020. PMID: 32246377
Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
Gombos A, Venet D, Ameye L, Vuylsteke P, Neven P, Richard V, Duhoux FP, Laes JF, Rothe F, Sotiriou C, Paesmans M, Awada A, Guiot T, Flamen P, Piccart-Gebhart M, Ignatiadis M, Gebhart G. Gombos A, et al. Among authors: awada a. NPJ Breast Cancer. 2022 Mar 16;8(1):38. doi: 10.1038/s41523-022-00409-x. NPJ Breast Cancer. 2022. PMID: 35296682 Free PMC article. No abstract available.
Targeted therapy for breast cancer in older patients.
Pondé N, Wildiers H, Awada A, de Azambuja E, Deliens C, Lago LD. Pondé N, et al. Among authors: awada a. J Geriatr Oncol. 2020 Apr;11(3):380-388. doi: 10.1016/j.jgo.2019.05.012. Epub 2019 Jun 4. J Geriatr Oncol. 2020. PMID: 31171494 Review.
FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
Gombos A, Venet D, Ameye L, Vuylsteke P, Neven P, Richard V, Duhoux FP, Laes JF, Rothe F, Sotiriou C, Paesmans M, Awada A, Guiot T, Flamen P, Piccart-Gebhart M, Ignatiadis M, Gebhart G. Gombos A, et al. Among authors: awada a. NPJ Breast Cancer. 2021 Sep 21;7(1):125. doi: 10.1038/s41523-021-00331-8. NPJ Breast Cancer. 2021. PMID: 34548493 Free PMC article.
Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial.
Caparica R, Ma Y, De Angelis C, Richard F, Desmedt C, Awada A, Piccart M, Perez EA, Moreno-Aspitia A, Badve S, Thompson EA, de Azambuja E. Caparica R, et al. Among authors: awada a. Clin Breast Cancer. 2022 Jun;22(4):308-318. doi: 10.1016/j.clbc.2021.11.012. Epub 2021 Dec 2. Clin Breast Cancer. 2022. PMID: 34980541 Free PMC article. Clinical Trial.
548 results